Cargando…
BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer
BACKGROUND: Brother of regulator of imprinted sites (BORIS) is expressed in most cancers and often associated with short survival and poor prognosis in patients. BORIS inhibits apoptosis and promotes proliferation of cancer cells. However, its mechanism of action has not been elucidated, and there i...
Autores principales: | Zhang, Yanmei, Fang, Mengdie, Li, Shouye, Xu, Hao, Ren, Juan, Tu, Linglan, Zuo, Bowen, Yao, Wanxin, Liang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344678/ https://www.ncbi.nlm.nih.gov/pubmed/35918747 http://dx.doi.org/10.1186/s12943-022-01621-w |
Ejemplares similares
-
BORIS-mediated generation of circular RNAs induces inflammation
por: Xu, Hao, et al.
Publicado: (2022) -
Arginine-Specific Mono ADP-Ribosylation In Vitro of Antimicrobial Peptides by ADP-Ribosylating Toxins
por: Castagnini, Marta, et al.
Publicado: (2012) -
Molecular Tools for the Study of ADP‐Ribosylation: A Unified and Versatile Method to Synthesise Native Mono‐ADP‐Ribosylated Peptides
por: Voorneveld, Jim, et al.
Publicado: (2021) -
ADP-ribosylation of arginine
por: Laing, Sabrina, et al.
Publicado: (2010) -
Reversing ADP-ribosylation
por: Moeller, Giuliana Katharina, et al.
Publicado: (2017)